From our sister brand, Managed Healthcare Executive: At the 2019 Asembia Specialty Pharmacy Summit, an expert discussed the role that specialty pharmacy can play in facilitating contemporary rare disease treatment and channel strategy approaches in the future.
FDA approved several important new therapies, including the first anticoagulant for
children, an injectable for diabetic retinopathy, and a treatment for renal cell
carcinoma. Here are the top 3 new drug approvals.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA